Praxis Precision Medicines, Inc. (PRAX)
357.50
+4.06
(+1.15%)
USD |
NASDAQ |
Sep 02, 16:00
356.80
-0.70
(-0.20%)
Pre-Market: 08:52
Praxis Precision Medicines Research and Development Expense (TTM) : 290.71M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 290.71M |
| March 31, 2026 | 284.30M |
| December 31, 2025 | 267.12M |
| September 30, 2025 | 245.90M |
| June 30, 2025 | 221.98M |
| March 31, 2025 | 186.24M |
| December 31, 2024 | 152.41M |
| September 30, 2024 | 114.51M |
| June 30, 2024 | 89.89M |
| March 31, 2024 | 88.25M |
| December 31, 2023 | 86.77M |
| September 30, 2023 | 96.71M |
| June 30, 2023 | 109.89M |
| Date | Value |
|---|---|
| March 31, 2023 | 127.89M |
| December 31, 2022 | 155.04M |
| September 30, 2022 | 170.22M |
| June 30, 2022 | 172.92M |
| March 31, 2022 | 154.98M |
| December 31, 2021 | 120.26M |
| September 30, 2021 | 93.02M |
| June 30, 2021 | 72.66M |
| March 31, 2021 | 56.04M |
| December 31, 2020 | 44.98M |
| September 30, 2020 | 34.40M |
| June 30, 2020 | 30.96M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Heron Therapeutics, Inc. | 12.00M |
| Insmed, Inc. | 860.84M |
| Ionis Pharmaceuticals, Inc. | 923.08M |
| Perspective Therapeutics, Inc. | 82.13M |
| Regeneron Pharmaceuticals, Inc. | 5.748B |